Home » About Us » Our Staff » Monica Heger

Monica Heger

Editor
Phone Number
+1-917-741-0410
Email
mheger@genomeweb.com
Monica Heger at Genomeweb / 360dx Monica Heger at Genomeweb / 360dx

Monica Heger tracks trends in next-generation sequencing for research and clinical applications for GenomeWeb.

Articles Authored by Monica Heger

Jan 18, 2019

PacBio Describes Circular Consensus Sequencing Protocol for Accurate Variant Calling and Assembly

Premium

PacBio is looking to increase the yield and reduce the cost of the protocol, which enables long reads and accurate sequencing.

Jan 16, 2019

Minimal Residual Disease Sequencing Poised to Grow Following Lag in Adoption

Premium

Despite initial promise, NGS-based MRD detection has not been broadly adopted, but improvements in technology and more clinical utility data may change that.

Jan 11, 2019

JP Morgan Healthcare, Day 4: Meridian Bioscience, Genapsys, Biocartis, Veracyte

Meridian CEO Jack Kenny said the firm needs to develop a new MDx platform, while Genapsys resurfaced with an update on its portable sequencing platform.

Jan 10, 2019

NanoString on Target to Launch Digital Spatial Profiler at AACR, CEO Says at JP Morgan Conference

CEO Brad Gray told investors at the JP Morgan Healthcare Conference that he believes the firm's GeoMx has advantages over competitors in the new market.

Jan 10, 2019

JP Morgan Healthcare, Day 3: Luminex, GenMark, Bio-Techne, Quanterix, PerkinElmer, MGI, and More

Among the updates provided at the conference on Wednesday, Luminex discussed development and plans for the Verigene II system, and GenMark touted its ePlex test portfolio.

Jan 10, 2019

New Natera CEO Highlights Three Goals for Company at JP Morgan

The company plans to focus on increasing its NIPT reimbursement as well as on pharmaceutical deals for its oncology test and launching a kidney transplantation test.

Jan 09, 2019

Adaptive Biotechnologies to Leverage Genentech, Microsoft Deals to Advance Immune Profiling Business

The company is also looking to expand the use of its FDA-approved ClonoSeq assay, which has US FDA approval for MRD detection in acute lymphocytic leukemia and multiple myeloma.

Jan 09, 2019

JP Morgan Healthcare, Day 2: Thermo Fisher, Exact Sciences, Guardant, Hologic, Caris, and More

A busy second day of the JP Morgan conference saw Thermo Fisher's Marc Casper discuss the firm's R&D focus and Exact Sciences' Kevin Conroy discuss plans for Cologuard sales growth.

Jan 08, 2019

Illumina to Launch New NovaSeq Chip, iSeq Kit; Grow Oncology and Reproductive Health Business

The firm's fourth quarter preliminary revenues increased by 11 percent to $865 million year over year, while full-year revenues jumped by 21 percent to $3.3 billion.

Jan 03, 2019

Chicago Team Develops Method for Sequencing Transfer RNAs in Microbiomes

Premium

The researchers plan to commercialize the method, which they said will help characterize how microbes respond to different environmental conditions.

The Scan

Mysterious Third Group

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

This Week in Science

In Science this week: reduction in bee phylogenetic diversity, and more.

In the Past

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.

New Bases, New Drugs

The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.